ONVO - Organovo Holdings, Inc.

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue4,2301,483571
Cost of Revenue956--
Gross Profit3,2741,483571
Operating Expenses
Research Development19,54518,00812,921
Selling General and Administrative22,30422,11817,947
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-38,575-38,643-30,297
Income from Continuing Operations
Total Other Income/Expenses Net15171216
Earnings Before Interest and Taxes-38,424-38,572-30,081
Interest Expense--1
Income Before Tax-38,424-38,572-30,082
Income Tax Expense233-
Minority Interest---
Net Income From Continuing Ops-38,447-38,575-30,082
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-38,447-38,575-30,082
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-38,447-38,575-30,082